Operating profit/loss (EBIT) of H. Lundbeck 2009-2019

The operating profit of the Danish pharmaceutical company H. Lundbeck fluctuated over the years, and in 2015, the company had their largest operating losses, at approximately 6.8 billion Danish kroner. The EBIT increased the following years, and from 2016 to 2018 the company made operating profits. In 2018, this amount was around 5.3 billion Danish kroner, while the EBIT decreased to rougly 3.6 billion Danish kroner in 2019.

Operating profit/loss (EBIT) of H. Lundbeck from 2009 to 2019

Operating profit in million DKK
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date

February 2020



Survey time period

2009 to 2019

Supplementary notes

H. Lundbeck A/S is a Danish pharmaceutical company founded in 1915 with its headquarter in Copenhagen. The key products produced by the company are pharmaceuticals for the nervous system.

Some figures have been taken from previous publications.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Zoetis"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.